జర్నల్ ఆఫ్ సెల్యులార్ అండ్ మాలిక్యులర్ ఫార్మకాలజీ

నైరూప్య

Mitosis Under Siege the Latest Advances in Mitotic Inhibitor Drug Development

Daisuke Nakanishi

This article delves into the forefront of cancer therapeutics, exploring the latest advances in the development of mitotic inhibitors. Mitosis, the pivotal process of cell division, forms the epicenter of cancer proliferation, making it a prime target for innovative drug interventions. We navigate through the diverse landscape of mitotic inhibitors, unraveling their mechanisms and the recent strides in precision medicine, combination therapies, and advanced drug delivery systems. As mitosis faces a relentless siege, this article outlines the promising developments that hold the potential to redefine cancer treatment strategies.